XML 36 R89.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation Stock Option Awards (Details) (USD $)
Share data in Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Exercised, Total Intrinsic Value $ 0 $ 22,000 $ 59,000
Compensation expense 2,618,000 4,609,000 448,000
Stock Options [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 4 years    
Stock option life (in years) 10    
Options, grants in period (in shares)   2,835 0
Grant Price (usd per share) $ 3.97    
Exercise Price (usd per share) $ 6.00    
Expected Life in Years 6.50    
Annualized Volatility 59.20%    
Annual Dividend Rate 0.00%    
Risk Free Rate 2.48%    
Fair Value 5,540,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at (in shares) 4,524 2,157 2,636
Granted (in shares)   2,835 0
Exercised (in shares)   (35) (30)
Forfeited (in shares) (203) (433) (173)
Expired (in shares) (130)   (276)
Outstanding at (in shares) 4,191 4,524 2,157
Vested and expected to vest at March 31, 2012 (in shares) 4,084    
Exercisable at March 31, 2012 (in shares) 1,931    
Weighted Average Exercise Price, Outstanding at (usd per share) $ 6.05 $ 6.24 $ 6.08
Exercised, Weighted Average Exercise Price (usd per share)   $ 2.98 $ 3.26
Forfeited, Weighted Average Exercise Price (usd per share) $ 5.98 $ 6.91 $ 6.46
Expired, Weighted Average Exercise Price (usd per share) $ 6.86   $ 4.89
Granted, Weighted Average Exercise Price (usd per share)   $ 6.00  
Weighted Average Exercise Price, Outstanding at (usd per share) $ 6.03 $ 6.05 $ 6.24
Vested and expected to vest at March 31, 2012, Weighted Average Exercise Price (usd per share) $ 6.03    
Exercisable at March 31 2012, Weighted Average Exercise Price (usd per share) $ 6.06    
Weighted Average Remaining Contractual Term, Outstanding at (in years) 7.31     
Vested and expected to vest at March 31, 2012, Weighted Average Remaining Contractual Term (in years) 7.27    
Exercisable at March 31, 2012, Weighted Average Remaining Contractual Term (in years) 5.36    
Outstanding at, Intrinsic Value 0     
Vested and expected to vest at March 31, 2012, Outstanding, Aggregate Intrinsic Value 0    
Exercisable at March 31, 2012, Intrinsic Value 0    
Compensation expense $ 907,000 $ 2,874,000 $ 1,090,000